G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
about
Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working GroupCosts and Cost-Effectiveness of Plasmodium vivax ControlAssessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern IndonesiaG6PD deficiency in Latin America: systematic review on prevalence and variantsMolecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Bangladeshi Individuals.The challenges of introducing routine G6PD testing into radical cure: a workshop report.Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles.Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of NepalRecombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiencyDiagnostic approaches for inherited hemolytic anemia in the genetic eraGlucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects.G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study.Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational StudyEffectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh.Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant.Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the PhilippinesCost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detectionDevelopment of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Trait among Prospective Blood Donors: A Cross-Sectional Study in Berekum, Ghana.Pharmacogenomic implications of the evolutionary history of infectious diseases in AfricaNational G6PD neonatal screening program in Gaza Strip of Palestine: rationale, challenges and recommendations.Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.Rapid diagnostic test for G6PD deficiency in Plasmodium vivax-infected men: a budget impact analysis based in Brazilian Amazon.Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.Methods for the field evaluation of quantitative G6PD diagnostics: a review.Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyondHow We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression.Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.
P2860
Q27304660-6F6FCD31-7EB8-4944-A6CF-40D471416664Q28355704-068766BD-67D7-4495-87F5-4B9938B8EA20Q28550280-7AB7C7D3-9E5C-4DAA-9EE4-E43CFE10E9E5Q29353696-6DC03A7B-3E84-4A4F-A44A-899560FCE21CQ30395566-827E67FA-E144-4120-A906-F9F933730EDCQ30666192-6C1BBA15-FD15-422C-9B3D-62E0195AAA99Q33563151-49F086FA-7415-46DF-A8E5-2D22EEDCB625Q33721887-1C031869-765E-45B3-BBDB-D87AB3BC0587Q33731882-4115C0F5-C8A0-4821-AA3F-2497732F4611Q33889987-1BDCBAE0-BF81-4814-866C-7FD3D3FF9EE7Q34058341-A5B62A1E-6498-4696-8729-7694A204B971Q34281695-41D09C2F-88E4-49F0-A5C9-0025556438E1Q34777088-23026067-0FB2-46B2-A38C-FAF3E9E64C4DQ35140594-F978BBC5-EFBF-4869-B4EB-0B82AE22C38BQ35237781-B63236B7-511C-4E95-9935-D845FE07856CQ35464096-35E0CFAD-7EA6-435F-90D6-88F48D4A6D42Q35865125-F3DE7046-2AE5-490D-8CAA-BEC7F518CAEEQ35976692-3A20BB4E-E6D7-40BF-AC2E-D36DE8C49AC9Q36003357-5032E507-6D5D-432B-BB01-480F46EEEA78Q36235143-1803FC41-E38F-4493-B8A7-CB70B8ED8A33Q36259682-58E8B9C4-5AC0-44CD-9C8C-FAF868F3C94EQ36337171-CD005A0F-6DD0-4852-8ABE-AC147817692AQ36454688-32FFC601-3E7E-4696-96CC-1DEAB877D412Q36551751-EE6E379F-0934-4768-8A70-58000847FD15Q36570456-B907D284-57A7-4D4D-B802-94EABB86AA70Q37024345-BEE4ACFF-BEF5-4976-833A-FA979021E249Q37119572-25D389E1-81ED-452B-9544-BC82777E1F00Q37290274-C4549806-D727-4FE8-B3EB-3BF168C41016Q37737731-53F80F59-1ADF-40ED-BB81-F52C7037161DQ38804223-B0D45F24-BD39-4FC1-97B9-405240127C48Q38852349-451F70E4-972B-4E7D-BA5E-D4E2ECFFE1A3Q38921632-B7E21320-63D1-419E-B575-B457FB12C602Q39346829-31E927FD-4D5A-48E6-A56E-953CE5750B74Q39413284-5DB4528F-0630-422E-A3D7-AE6F9E2A5C2AQ39587294-CAE81635-443A-4FA6-A641-DB88696DC6BDQ40053271-90F0F6BA-1B98-4949-906C-AD83038FEEB3Q42632539-3514BC48-E734-4F27-ABD5-C10EB5ED9F67Q47133461-65D63760-B312-45BD-B96A-F4B4C506DE61Q47294497-F4A370FC-4B9F-4CF4-97D9-E37B249D3014Q48021707-05C3FDB0-D923-4CF9-859D-613348F87F6D
P2860
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
G6PD testing in support of tre ...... for evaluation of G6PD tests.
@en
G6PD testing in support of tre ...... for evaluation of G6PD tests.
@nl
type
label
G6PD testing in support of tre ...... for evaluation of G6PD tests.
@en
G6PD testing in support of tre ...... for evaluation of G6PD tests.
@nl
prefLabel
G6PD testing in support of tre ...... for evaluation of G6PD tests.
@en
G6PD testing in support of tre ...... for evaluation of G6PD tests.
@nl
P2093
P2860
P50
P356
P1433
P1476
G6PD testing in support of tre ...... for evaluation of G6PD tests.
@en
P2093
Anup Anvikar
Arantxa Roca
Ari Winasti Satyagraha
Gonzalo J Domingo
Janice Culpepper
Jimee Hwang
Judith Recht
Justin Green
Kevin Baird
P2860
P2888
P356
10.1186/1475-2875-12-391
P577
2013-11-04T00:00:00Z
P5875
P6179
1040573899